Theralizumab
Product Specifications
CAS Number
906068-56-2
Target
Others|||Immunology/Inflammation related
Related Pathways
Others|||Immunology/Inflammation
Purity
0.9946
Bioactivity
Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells. Theralizumab has antitumor activity and is used for the treatment of B-cell chronic lymphocytic leukemia and rheumatoid arthritis.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/64416431076278315/T77093
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rat Monoclonal LIX1 Antibody (RM0282-4F47) [DyLight 350]](https://cdn.genprice.uk/genprice/genprice5.png)
MBS6290746-01 0.1 mL
DAG1, CT (DAG1, Dystroglycan, Dystrophin-associated glycoprotein 1, Alpha-dystroglycan, Beta-dystroglycan) (MaxLight 650)
Ask
View Details MBS6290746-02 5x 0.1 mL
DAG1, CT (DAG1, Dystroglycan, Dystrophin-associated glycoprotein 1, Alpha-dystroglycan, Beta-dystroglycan) (MaxLight 650)
Ask
View Details